Goldman Sachs cuts Nanobiotix stake to 3.78%
Bitget2026/09/21 11:17- Goldman Sachs cut its stake in Nanobiotix below 5% on Aug. 24.
- Holding fell to 1,921,176 shares, equal to 3.78% of share capital, 3.52% of voting rights.
- Move followed an off-market sale of shares.
- Position includes 1,478,840 shares via 17 cash-settled swap contracts, exercisable through Aug. 20, 2036.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of Canada Issues Strongest Stagflation Warning: Tariffs May Push Q4 Growth Below 1%, High Oil Prices Intensify Inflation
Bank of Canada Governor Macklem stated on Monday that a new round of U.S. tariffs could halve Canada’s fourth-quarter economic growth, dropping it below 1%, while annual inflation will remain at 3%, exceeding the 2% target. He added that if oil prices continue to hover around $100 per barrel, prices could be pushed even higher. Macklem said that if inflation is manageable, he does not want to raise interest rates; however, if inflation exceeds expectations, he also does not want to react too slowly.
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
Crypto prices
More
